Profiel
Kavita Aggarwal currently works at Verona Pharma Plc, as Senior Vice President-Medical Affairs from 2023.
Dr. Aggarwal also formerly worked at BioCryst Pharmaceuticals, Inc., as VP-Global Commercial Pipeline Strategy and Dova Pharmaceuticals, Inc., as Vice President-Medical Affairs.
Dr. Aggarwal received her undergraduate degree from North Carolina State University and doctorate degree from the University of North Carolina at Chapel Hill.
Actieve functies van Kavita Aggarwal
| Bedrijven | Functie | Begin |
|---|---|---|
| VERONA PHARMA PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
Eerdere bekende functies van Kavita Aggarwal
| Bedrijven | Functie | Einde |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Kavita Aggarwal
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















